P3 Health Partners Inc. provided earnings guidance for the full year ending December 31, 2023. For the period, the company expects total revenues to be in a range of $1,200 millions and $1,250 millions.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.607 USD | +12.99% | +22.35% | -56.59% |
Apr. 01 | BTIG Research Downgrades P3 Health Partners to Neutral From Buy | MT |
Mar. 28 | Transcript : P3 Health Partners Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.59% | 64.15M | |
-0.26% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.35% | 24.63B | |
-23.71% | 18.2B | |
+27.23% | 12.01B | |
-3.18% | 11.76B | |
+14.96% | 10.4B | |
-4.74% | 9.94B |
- Stock Market
- Equities
- PIII Stock
- News P3 Health Partners Inc.
- P3 Health Partners Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2023